Source: CNBC
“The Trump administration is preparing to impose new tariffs on [American buyers of] branded drugs from pharmaceutical companies that have not struck landmark deals with the president to lower their U.S. drug prices, CNBC has learned. [American buyers of] Patented medications and their active ingredients would be hit with a 100% tariff, according to a draft of the document obtained by CNBC. But there are pathways for drugmakers to reduce or avoid the levies [on American buyers] if they move their manufacturing to the U.S. or are negotiating deals with the administration. … The plan would represent another shift in Trump’s aggressive trade strategy, more than a month after the Supreme Court struck down the global levies he imposed in 2025, which excluded the pharmaceutical industry.” (04/02/26)
https://www.cnbc.com/2026/04/02/trump-pharmaceutical-tariffs-100percent.html